Nanobiotix Announces Voting Rights and Share Capital Details

Nanobiotix, a biotechnology company listed on Euronext Paris and Nasdaq, has disclosed its current share and voting rights details as of February 28, 2026. The company reported having 48,494,528 shares outstanding. The total number of theoretical voting rights stands at 50,197,214, while the exercisable voting rights are 50,175,096.

This information is provided in line with the regulations under the French Commercial Code and the General Regulation of the French Financial Markets Authority. These figures are crucial for shareholders and potential investors to understand the company’s market position and voting structure, ensuring transparency and informed decision-making.